Antiphospholipid syndrome

G Ruiz-Irastorza, M Crowther, W Branch… - The Lancet, 2010 - thelancet.com
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis;
pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental …

Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology

SA Kozek-Langenecker, A Afshari… - European Journal of …, 2013 - journals.lww.com
The aims of severe perioperative bleeding management are three-fold. First, preoperative
identification by anamesis and laboratory testing of those patients for whom the …

[图书][B] Goldman's cecil medicine E-book

L Goldman, AI Schafer - 2011 - books.google.com
Stay on the cutting edge with the newly revised eBook of Goldman's Cecil Medicine, with
over 400 updates personally selected by Dr. Lee Goldman and integrated directly into each …

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines

C Kearon, SR Kahn, G Agnelli, S Goldhaber… - Chest, 2008 - Elsevier
This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …

Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based …

TT Horlocker, DJ Wedel, JC Rowlingson… - Regional Anesthesia & …, 2010 - rapm.bmj.com
The actual incidence of neurologic dysfunction resulting from hemorrhagic complications
associated with neuraxial blockade is unknown. Although the incidence cited in the literature …

Apixaban, an oral, direct factor X a inhibitor: Single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

C Frost, J Wang, S Nepal, A Schuster… - British Journal of …, 2013 - Wiley Online Library
Aims To evaluate apixaban single dose safety, tolerability, pharmacokinetics and
pharmacodynamics and assess the effect of food on apixaban pharmacokinetics. Methods A …

[HTML][HTML] Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate

H Zahir, KS Brown, AG Vandell, M Desai, JF Maa… - Circulation, 2015 - journals.lww.com
Background—The oral factor Xa inhibitor edoxaban has demonstrated safety and efficacy in
stroke prevention in patients with atrial fibrillation and in the treatment and secondary …

Rational approaches to improving selectivity in drug design

DJ Huggins, W Sherman, B Tidor - Journal of medicinal chemistry, 2012 - ACS Publications
Appropriate tuning of binding selectivity is a primary objective in the discovery and
optimization of a compound on the path toward developing a drug. The environment in …

Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology

W Gogarten, E Vandermeulen… - European Journal of …, 2010 - journals.lww.com
Background The first national recommendations on neuraxial anaesthesia and
antithrombotic drugs were published by the German Society for Anaesthesiology and …

Dabigatran etexilate: a new oral thrombin inhibitor

GJ Hankey, JW Eikelboom - Circulation, 2011 - Am Heart Assoc
For the past 60 years, oral vitamin K antagonists (eg, warfarin, acenocoumarol,
phenprocoumon, fluindione) have been widely prescribed. 5 However, their impact in …